Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Pacific Biosciences of California (PACB) ended the recent trading session at $1.22, demonstrating a +1.67% swing from the preceding day's closing price. The stock's change was less than the S&P 500's ...

Explore Pacific Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PACB. Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific ...

Pacific Biosciences of California (PACB) closed the latest trading day ... estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank ...

Bernstein analyst Eve Burstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.

New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – ...

3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever PACB stock opened at $1.56 on Tuesday. Pacific Biosciences of California has a 12-month low of $1.16 ...

Pacific Biosciences' Q4'24 results were another disappointment ... Growth in clinical and diagnostic markets will help, but not right away, and PACB is likely to remain below $100M in annualized ...

MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported fourth-quarter profit of $3.6 million. The Menlo Park, California-based ...